The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) supports science and research initiatives in the fields of Clinical Microbiology (CM) and Infectious Diseases (ID), offering support to a range of projects and programmes to enhance knowledge, promote development, and strengthen defences against emerging global threats.
EUCAST defines critical guidelines to interpret AMR, functioning as the breakpoint committee of the European Medicines Agency (EMA) and the European Centre for Diseases Prevention Control (ECDC).
The EUCIC strengthens infection control and preventive measures across Europe to reduce the burden of Healthcare-Associated Infections (HAIs) through an expansive network of resources and support.
The ESCMID AMR Action Subcommittee advocates and promotes AMR-related activities to relevant stakeholders. AMR action is a strategic priority for ESCMID.
ESCMID acknowledges past achievements and incentivises future accomplishments by providing grants and prestigious awards.
